No Data
Strong performance, with dip buying favored due to the rise in US stocks.
[Emerging Markets Individual Stock Strategy] Today's emerging markets are expected to show a robust performance. Last weekend, on the 7th, the U.S. stock market saw the Dow Inc average rise by 222.64 dollars (+0.52%) to 42,801.72 dollars. Employment Statistics indicated some signs of a slowdown in employment, raising concerns about growth that weighed on stock prices. On the other hand, Federal Reserve Chair Powell reaffirmed in a speech that there are no issues with the economy and confirmed a stance of keeping policies steady for the time being, which supported the stock prices and expanded the gains towards the end of the session.
Japan skiing, Oncolis Bio and others.
A capital and business alliance agreement has been concluded with HUMEDIT, which handles various tests (NIPT/NI-PGS/PCR) such as the issuance of new stocks through third-party allocation (0.07 million3099 shares) and the disposal of treasury shares (0.18 million201 shares). ＜4584＞ Kids Bio had a large exercise of subscription rights (with price adjustment clauses) from the 24th, with the number of shares to be delivered starting from the 5th being 0.9 million shares. ＜4588＞ Oncolys Bio is conducting clinical research on the next-generation tumor lytic virus OBP-702.
J Frontier: Corrected Financial Report - 16th Term (2023/06/01－2024/05/31)
Individual stock information.
ALiNK <7077.T> rebounds. From the shareholder benefits based on the date of February 28, 2026, a preferential system for long-term shareholding will be introduced. A strategic partnership has been established with Karada Note <4014.T> and Welldy <2901.T>. As a result, Welldy will acquire the home delivery water business (Karada Note Water business) operated by the company for 160 million yen. Furthermore, starting from food and Health Care, the two companies aim to create new value by merging their assets in the future. Stock price
Japan's Food Inflation Is Becoming Harder for BOJ to Overlook
J Frontier: Publication of transcribed articles and frequently asked questions and answers from the financial results briefing for the 2nd quarter of the fiscal year ending May 2025